Quest Diagnostics Q4 2024 Earnings Report $163.97 +8.53 (+5.49%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast Quest Diagnostics EPS ResultsActual EPS$2.23Consensus EPS $2.19Beat/MissBeat by +$0.04One Year Ago EPSN/AQuest Diagnostics Revenue ResultsActual RevenueN/AExpected Revenue$2.58 billionBeat/MissN/AYoY Revenue GrowthN/AQuest Diagnostics Announcement DetailsQuarterQ4 2024Date1/30/2025TimeBefore Market OpensConference Call ResourcesConference CallDGX Earnings History Quest Diagnostics Earnings HeadlinesQuest Diagnostics increases quarterly dividend 6.7% to 80c per shareJanuary 30 at 4:39 PM | markets.businessinsider.comQuest Diagnostics Delivers Q4 Earnings Beat: The DetailsJanuary 30 at 4:39 PM | benzinga.comA new coin is elbowing its way to the top of the crypto worldWith Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.January 30, 2025 | Weiss Ratings (Ad)Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive YearJanuary 30 at 4:14 PM | prnewswire.comWhy Quest Diagnostics Stock Was Blasting Higher TodayJanuary 30 at 4:07 PM | fool.comQuest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call TranscriptJanuary 30 at 3:01 PM | seekingalpha.comSee More Quest Diagnostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Quest Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your email. Email Address About Quest DiagnosticsQuest Diagnostics (NYSE:DGX) provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.View Quest Diagnostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings AbbVie (1/31/2025)AON (1/31/2025)Colgate-Palmolive (1/31/2025)Chevron (1/31/2025)Eaton (1/31/2025)W.W. Grainger (1/31/2025)Novartis (1/31/2025)Snowflake (1/31/2025)Itaú Unibanco (2/2/2025)NXP Semiconductors (2/3/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
